Advances in Oncology, 2025: Advances, cartea 5-1
Editat de Leonidas C. Plataniasen Limba Engleză Hardback – 22 mai 2025
Din seria Advances
- 5%
Preț: 720.33 lei - 5%
Preț: 952.85 lei - 5%
Preț: 1234.55 lei - 5%
Preț: 932.16 lei - 5%
Preț: 1232.56 lei - 5%
Preț: 1164.83 lei - 5%
Preț: 1163.45 lei - 5%
Preț: 1233.31 lei - 5%
Preț: 1274.99 lei - 5%
Preț: 1127.64 lei - 25%
Preț: 737.37 lei - 25%
Preț: 670.71 lei - 30%
Preț: 986.68 lei - 5%
Preț: 822.83 lei - 30%
Preț: 977.14 lei - 25%
Preț: 666.98 lei - 25%
Preț: 590.62 lei - 25%
Preț: 709.57 lei - 25%
Preț: 735.94 lei - 25%
Preț: 860.88 lei - 25%
Preț: 807.44 lei - 25%
Preț: 791.35 lei - 25%
Preț: 809.13 lei - 25%
Preț: 871.01 lei - 30%
Preț: 872.02 lei - 5%
Preț: 493.69 lei - 30%
Preț: 596.38 lei - 25%
Preț: 975.82 lei - 25%
Preț: 671.31 lei - 25%
Preț: 808.34 lei - 32%
Preț: 850.23 lei - 30%
Preț: 858.45 lei - 5%
Preț: 855.72 lei - 25%
Preț: 984.69 lei - 25%
Preț: 689.09 lei - 25%
Preț: 800.14 lei - 25%
Preț: 908.34 lei - 5%
Preț: 907.78 lei - 5%
Preț: 910.14 lei - 25%
Preț: 594.42 lei - 5%
Preț: 854.93 lei - 30%
Preț: 856.93 lei - 25%
Preț: 885.64 lei - 33%
Preț: 854.96 lei - 25%
Preț: 836.55 lei - 5%
Preț: 907.68 lei - 5%
Preț: 492.96 lei - 5%
Preț: 908.66 lei - 27%
Preț: 594.93 lei
Preț: 1317.29 lei
Preț vechi: 1386.62 lei
-5% Nou
Puncte Express: 1976
Preț estimativ în valută:
233.11€ • 271.84$ • 204.67£
233.11€ • 271.84$ • 204.67£
Carte tipărită la comandă
Livrare economică 15-29 ianuarie 26
Preluare comenzi: 021 569.72.76
Specificații
Cuprins
SECTION I: RADIATION ONCOLOGY
Adaptative Radiation Therapy
Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders
SECTION II: SURGICAL ONCOLOGY
Neoadjuvant Treatment Strategies in Gastrointestinal Stromal Tumors
Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors
Contemporary Approaches to Adrenocortical Carcinoma
SECTION III: MEDICAL ONCOLOGY
State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer
Integration of Early Palliative Care in Personalized Cancer Care
Treatment Advances in Small Cell Lung Cancer
SECTION IV: GYNECOLOGIC ONCOLOGY
Emerging Therapeutic Targets for Platinum Resistant Ovarian Cancer
Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer
SECTION V: PEDIATRIC ONCOLOGY
Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions
Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations
Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors
SECTION VI: NEURO-ONCOLOGY
Treatment of Isocitrate Dehydrogenase Mutant Gliomas
Exosomes in Glioma: Diagnostic and Therapeutic Potentials
Maximal Extent of Resection, Including Supramaximal Resection, for Diffuse Gliomas
SECTION VII: HEMATOLOGICAL ONCOLOGY
Will Triplet Therapy Become Standard of Care in Acute Myeloid Leukemia?
Current and Future Approaches for the Treatment of Plasma Cell Leukemia
Germline Testing in Hematopoietic Malignancies: Whom to Test, When, How, and Why
SECTION VIII: URO-ONCOLOGY
Bladder-Sparing Approaches in Muscle Invasive Bladder Cancer
Adjuvant Therapy in Renal Cell Carcinoma: Current Landscape and Future Directions
Poly-ADP Ribose Polymerase Inhibitors and Combinations in Metastatic Prostate Cancer
SECTION IX: GASTROINTESTINAL ONCOLOGY
The Potential Role of Circulating Tumor DNA as a Tool in the Management of Gastrointestinal Malignancies
How I Treat Advanced Biliary Cancer
Disparities Along the Cancer Care Continuum: The Role of Social Drivers of Health on Gastrointestinal Malignancies
Adaptative Radiation Therapy
Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders
SECTION II: SURGICAL ONCOLOGY
Neoadjuvant Treatment Strategies in Gastrointestinal Stromal Tumors
Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors
Contemporary Approaches to Adrenocortical Carcinoma
SECTION III: MEDICAL ONCOLOGY
State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer
Integration of Early Palliative Care in Personalized Cancer Care
Treatment Advances in Small Cell Lung Cancer
SECTION IV: GYNECOLOGIC ONCOLOGY
Emerging Therapeutic Targets for Platinum Resistant Ovarian Cancer
Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer
SECTION V: PEDIATRIC ONCOLOGY
Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions
Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations
Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors
SECTION VI: NEURO-ONCOLOGY
Treatment of Isocitrate Dehydrogenase Mutant Gliomas
Exosomes in Glioma: Diagnostic and Therapeutic Potentials
Maximal Extent of Resection, Including Supramaximal Resection, for Diffuse Gliomas
SECTION VII: HEMATOLOGICAL ONCOLOGY
Will Triplet Therapy Become Standard of Care in Acute Myeloid Leukemia?
Current and Future Approaches for the Treatment of Plasma Cell Leukemia
Germline Testing in Hematopoietic Malignancies: Whom to Test, When, How, and Why
SECTION VIII: URO-ONCOLOGY
Bladder-Sparing Approaches in Muscle Invasive Bladder Cancer
Adjuvant Therapy in Renal Cell Carcinoma: Current Landscape and Future Directions
Poly-ADP Ribose Polymerase Inhibitors and Combinations in Metastatic Prostate Cancer
SECTION IX: GASTROINTESTINAL ONCOLOGY
The Potential Role of Circulating Tumor DNA as a Tool in the Management of Gastrointestinal Malignancies
How I Treat Advanced Biliary Cancer
Disparities Along the Cancer Care Continuum: The Role of Social Drivers of Health on Gastrointestinal Malignancies